Key To Growing Probiotic Sales: Talk Benefits, Not Bacteria
This article was originally published in The Tan Sheet
Emphasize probiotics’ benefits rather than touting research supporting claims or using the technical terms linked to bacteria strains, says Mintel’s Lynn Dornblaser. P&G.’s Meta line capitalizes on consumers’ growing affinity for probiotics with the right approach to promote the brand.
You may also be interested in...
Research on probiotics’ health benefits rapidly grows, but turning studies into label claims lags due to differences between industry, NIH and FDA about standards for claims substantiation. Attendees at a U.S. Pharmacopeia conference outline the challenges to finding common ground
“We ought to deal with this. There are questions on long-term safety and questions on efficacy claims that are just not proven,” says the Maryland Republican. “The biggest threat hanging over, in my mind, the farmers who want to grow hemp, is what if the FDA comes out tomorrow and says, ‘You can't sell any product’? The market collapses,”he said at a CBD policy conference.
Minnesota Democrat Collin Peterson’s bill, the first targeting FDA’s CBD question, could provide an entire answer or it could set table for discussion in Congress about legislation on establishing an FDA regulation on using CBD, and potentially other hemp-derived substances, in products other than drugs subject to its oversight.